BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10364247)

  • 1. Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity.
    Shaked GM; Fridlander G; Meiner Z; Taraboulos A; Gabizon R
    J Biol Chem; 1999 Jun; 274(25):17981-6. PubMed ID: 10364247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.
    Shaked GM; Meiner Z; Avraham I; Taraboulos A; Gabizon R
    J Biol Chem; 2001 Apr; 276(17):14324-8. PubMed ID: 11152454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis.
    McKinley MP; Meyer RK; Kenaga L; Rahbar F; Cotter R; Serban A; Prusiner SB
    J Virol; 1991 Mar; 65(3):1340-51. PubMed ID: 1704926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
    Thackray AM; Hopkins L; Bujdoso R
    Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease.
    Zou WQ; Capellari S; Parchi P; Sy MS; Gambetti P; Chen SG
    J Biol Chem; 2003 Oct; 278(42):40429-36. PubMed ID: 12917418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.
    Xiong LW; Raymond LD; Hayes SF; Raymond GJ; Caughey B
    J Neurochem; 2001 Nov; 79(3):669-78. PubMed ID: 11701770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
    Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
    PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mechanisms of degeneration of the central nervous system--prion structure and biology.
    Prusiner SB; Stahl N; DeArmond SJ
    Ciba Found Symp; 1988; 135():239-60. PubMed ID: 2900720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain.
    Kocisko DA; Lansbury PT; Caughey B
    Biochemistry; 1996 Oct; 35(41):13434-42. PubMed ID: 8873612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the biology of prions.
    Prusiner SB; Gabizon R; McKinley MP
    Acta Neuropathol; 1987; 72(4):299-314. PubMed ID: 3554880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical factors influencing prion inactivation by sodium hydroxide.
    Bauman PA; Lawrence LA; Biesert L; Dichtelmüller H; Fabbrizzi F; Gajardo R; Gröner A; Jorquera JI; Kempf C; Kreil TR; von Hoegen I; Pifat DY; Petteway SR; Cai K
    Vox Sang; 2006 Jul; 91(1):34-40. PubMed ID: 16756599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains.
    Yuan J; Xiao X; McGeehan J; Dong Z; Cali I; Fujioka H; Kong Q; Kneale G; Gambetti P; Zou WQ
    J Biol Chem; 2006 Nov; 281(46):34848-58. PubMed ID: 16987816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity.
    Riesner D; Kellings K; Post K; Wille H; Serban H; Groth D; Baldwin MA; Prusiner SB
    J Virol; 1996 Mar; 70(3):1714-22. PubMed ID: 8627692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility of scrapie-associated prion protein aggregation.
    Callahan MA; Xiong L; Caughey B
    J Biol Chem; 2001 Jul; 276(30):28022-8. PubMed ID: 11375994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
    Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creutzfeldt-Jakob disease and scrapie prions.
    Prusiner SB
    Alzheimer Dis Assoc Disord; 1989; 3(1-2):52-78. PubMed ID: 2568118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
    Prusiner SB
    Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse-adapted ovine scrapie prion strains are characterized by different conformers of PrPSc.
    Thackray AM; Hopkins L; Klein MA; Bujdoso R
    J Virol; 2007 Nov; 81(22):12119-27. PubMed ID: 17728226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.